Table 1.
Patients’ characteristics
| Characteristics | Media (range) or N (%) |
|---|---|
| Media of age (years) |
46 (23–68) |
| Media of follow-up (months) |
67 (6 –90) |
| Pathologic type |
|
| Squamous |
506 (83.1) |
| Adenocarcinoma |
74 (12.2) |
| Adenosquamous |
29 (4.7) |
| Size of primary tumor |
|
| ≤4 cm |
481 (79.0) |
| >4 cm |
128 (21.0) |
| Histologic grade |
|
| G1 |
61 (10.0) |
| G2 |
243 (39.9) |
| G3 |
305 (50.1) |
| Depth of primary tumor invasion |
|
| ≤1/2 |
355 (58.3) |
| >1/2 |
254 (41.7) |
| Stage (FIGO) |
|
| IA2 |
95 (15.6) |
| IB1 |
317 (52.1) |
| IB2 |
73 (12.0) |
| IIA1 |
69 (11.3) |
| IIA2 |
55 (9.0) |
| Lymph-vascular space invasion |
|
| No |
518 (85.1) |
| Yes |
91 (14.9) |
| Lymphadenectomy |
|
| Pelvic |
549 (90.1) |
| Pelvic + Periaortic |
60 (9.9) |
| Neo-adjuvant chemotherapy |
|
| Yes |
128 (21.0) |
| No |
481 (79.0) |
| Adjuvant therapy |
|
| None |
451 (74.1) |
| Concurrent chemoradiation |
158 (25.9) |
| Lymph nodes metastasis |
|
| No |
516 (84.7) |
| Yes | 93 (15.3) |